Evaluation of Treatments to Improve Smoking Cessation Medication Adherence

• Status: Completed
• Trial end date: 2014-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Many smokers fail to take their smoking cessation medication as recommended. This research is designed to identify treatments that improve the use of cessation medications and to determine whether an increase in medication use results in increased cessation success. This research will also identify treatments that help people stay quit after a quit attempt and will pioneer more efficient research methods.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Wisconsin, Madison
• Collaborators: Aurora Health Care; Dean Health System; Mercy Health System; Mercy Health System, Wisconsin; National Cancer Institute (NCI)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• 18 years of age or older;

• Report smoking at least 5 cigarettes per day for the previous 6 months;

• Able to read and write English;

• Agree to attend visits, to respond to coaching calls, and to respond to Interactive Voice Response (IVR) phone prompts;

• Plans to remain in the intervention catchment area for at least 12 months;

• Currently interested in quitting smoking (defined as would like to try to quit in the next 30 days).

• All women of childbearing potential will be required to agree to use an acceptable method of birth control to prevent pregnancy during the study.

Exclusion Criteria:

• Currently taking bupropion, Wellbutrin, chantix or varenicline (current use of NRT is not exclusionary if the participant agrees to use only study medication for the duration of the study);

• Study candidate is pregnant, trying to get pregnant, or nursing.

• A history of psychosis or bipolar disorder

• A history of skin or allergic reactions while using a nicotine patch.

• Had a heart attack, stroke, or abnormal electrocardiogram within the past 4 weeks.